Please login to the form below

Not currently logged in
Email:
Password:

Stiolto

This page shows the latest Stiolto news and features for those working in and with pharma, biotech and healthcare.

Boehringer Ingelheim calls for "strong and united" Europe

Boehringer Ingelheim calls for

Boehringer is hoping to migrate patients to new combination therapy Spiolto/Stiolto (tiotropium plus olodaterol) but with the asthma and COPD category becoming increasingly crowded and price-sensitive the combination is

Latest news

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Redline Strategic

We are a healthcare consultancy, specialising in people and experiences. Using innovative research methods to capture the thoughts of real...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics